Rhön-Klinikum Aktiengesellschaft (ETR:RHK) has been assigned a €22.00 ($25.58) price objective by investment analysts at Deutsche Bank AG in a research note issued to investors on Monday. The firm presently has a “neutral” rating on the stock. Deutsche Bank AG’s price target would indicate a potential downside of 26.72% from the stock’s current price.
RHK has been the topic of several other research reports. Warburg Research set a €26.00 ($30.23) price objective on Rhön-Klinikum Aktiengesellschaft and gave the company a “neutral” rating in a report on Thursday, August 3rd. Independent Research GmbH set a €28.00 ($32.56) price objective on Rhön-Klinikum Aktiengesellschaft and gave the company a “neutral” rating in a report on Monday, August 14th. Baader Bank set a €24.00 ($27.91) price objective on Rhön-Klinikum Aktiengesellschaft and gave the company a “neutral” rating in a report on Friday, November 10th. Commerzbank Ag set a €25.00 ($29.07) price objective on Rhön-Klinikum Aktiengesellschaft and gave the company a “neutral” rating in a report on Monday, September 18th. Finally, DZ Bank AG reissued a “sell” rating on shares of Rhön-Klinikum Aktiengesellschaft in a report on Tuesday, August 29th. Four equities research analysts have rated the stock with a sell rating and six have issued a hold rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of €25.05 ($29.13).
Shares of Rhön-Klinikum Aktiengesellschaft (ETR RHK) opened at €30.02 ($34.91) on Monday. Rhön-Klinikum Aktiengesellschaft has a twelve month low of €22.66 ($26.35) and a twelve month high of €30.65 ($35.64).
TRADEMARK VIOLATION NOTICE: “Rhön-Klinikum Aktiengesellschaft (RHK) PT Set at €22.00 by Deutsche Bank AG” was published by Stock Observer and is the property of of Stock Observer. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.thestockobserver.com/2017/11/15/rhon-klinikum-aktiengesellschaft-rhk-pt-set-at-22-00-by-deutsche-bank-ag.html.
Rhön-Klinikum Aktiengesellschaft Company Profile
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.
Receive News & Ratings for Rhön-Klinikum Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhön-Klinikum Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.